Invesaro

Stocks Comparison

Acadia Healthcare vs BioCorRx: revenue, profit, margins and growth compared

Acadia Healthcare brought in $3.3B of revenue in fiscal 2025, BioCorRx $797.2K in fiscal 2025. Revenue changed by +5.0% at Acadia Healthcare and +10,301.1% at BioCorRx on the year before, so BioCorRx grew faster. Acadia Healthcare kept -33.3% of its revenue as net profit, BioCorRx -431.5%.

Side by side, latest fiscal year

ACHCBICX
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$3.3B$797.2K
Revenue growth+5.0%+10,301.1%
Net income-$1.1B-$3.4M
Net margin-33.3%-431.5%
Free cash flow-$439.9Mn/a
Free cash flow margin-13.3%n/a
Earnings per share (diluted)-$12.16-$0.19
Cash$133.2M$139.4K
Debt$2.5Bn/a
Price to earningsn/an/a
Market value$2.6B$6M
Dividend yieldn/an/a
Rank by revenue in sector#83 of 742 · Health care#655 of 742 · Health care

Over the years

Revenue
ACHC FY2018: $1.9BACHC FY2019: $2BACHC FY2020: $2.1BACHC FY2021: $2.3BACHC FY2022: $2.6BACHC FY2023: $2.9BACHC FY2024: $3.2BACHC FY2025: $3.3BBICX FY2018: $376.7KBICX FY2019: $240.3KBICX FY2020: $122.6KBICX FY2021: $48.3KBICX FY2022: $213.8KBICX FY2023: $89.2KBICX FY2024: $7.7KBICX FY2025: $797.2KFY18FY19FY20FY21FY22FY23FY24FY25
ACHC $3.3BBICX $797.2K
Net income
ACHC FY2018: -$175.8MACHC FY2019: $108.9MACHC FY2020: -$672.1MACHC FY2021: $190.6MACHC FY2022: $273.1MACHC FY2023: -$21.7MACHC FY2024: $255.6MACHC FY2025: -$1.1BBICX FY2018: -$6.6MBICX FY2019: -$6MBICX FY2020: -$3.5MBICX FY2021: -$5.2MBICX FY2022: -$4.4MBICX FY2023: -$3.8MBICX FY2024: -$5.1MBICX FY2025: -$3.4MFY18FY19FY20FY21FY22FY23FY24FY25
ACHC -$1.1BBICX -$3.4M
Net margin
ACHC FY2018: -9.2%ACHC FY2019: 5.4%ACHC FY2020: -32.2%ACHC FY2021: 8.2%ACHC FY2022: 10.5%ACHC FY2023: -0.7%ACHC FY2024: 8.1%ACHC FY2025: -33.3%BICX FY2018: -1,748.1%BICX FY2019: -2,517.4%BICX FY2020: -2,859.6%BICX FY2021: -10,794.3%BICX FY2022: -2,046.8%BICX FY2023: -4,228.9%BICX FY2024: -66,616.1%BICX FY2025: -431.5%FY18FY19FY20FY21FY22FY23FY24FY25
ACHC -33.3%BICX -431.5%
Revenue growth
ACHC FY2019: +5.4%ACHC FY2020: +4.1%ACHC FY2021: +10.7%ACHC FY2022: +12.8%ACHC FY2023: +12.2%ACHC FY2024: +7.7%ACHC FY2025: +5.0%BICX FY2019: -36.2%BICX FY2020: -49.0%BICX FY2021: -60.6%BICX FY2022: +343.0%BICX FY2023: -58.3%BICX FY2024: -91.4%BICX FY2025: +10,301.1%FY19FY20FY21FY22FY23FY24FY25
ACHC +5.0%BICX +10,301.1%
Free cash flow
ACHC FY2018: $160.9MACHC FY2019: $100.2MACHC FY2020: $433.8MACHC FY2021: $129.7MACHC FY2022: $84.4MACHC FY2023: $38.2MACHC FY2024: -$560.7MACHC FY2025: -$439.9MBICX FY2018: -$1.8MBICX FY2019: -$2.8MBICX FY2020: -$2.2MBICX FY2021: -$3.5MBICX FY2022: -$2MFY18FY19FY20FY21FY22FY23FY24FY25
ACHC -$439.9MBICX -$2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Acadia Healthcare and BioCorRx

Which is bigger by revenue, Acadia Healthcare or BioCorRx?

Acadia Healthcare is bigger by revenue: $3.3B in fiscal 2025, against $797.2K for BioCorRx in fiscal 2025.

Which keeps more of its revenue as profit, Acadia Healthcare or BioCorRx?

Acadia Healthcare had a net margin of -33.3% in fiscal 2025; BioCorRx had -431.5% in fiscal 2025.

Which grew revenue faster, Acadia Healthcare or BioCorRx?

In their latest fiscal years revenue changed by +5.0% at Acadia Healthcare and +10,301.1% at BioCorRx.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies